Showing results (381-390 of 411) with videos related to
Sort By:
Pageof 42
Biorxiv : the Preprint Server for Biology|March 10, 2025
Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYCHannah T Rosen, Kelvin Li, Erin L Li, et al.Environmental Science & Technology|July 1, 2020
High-Resolution Mass Spectrometry Identification of Novel Surfactant-Derived Sulfur-Containing Disinfection Byproducts from Gas Extraction WastewaterHannah K Liberatore, Danielle C Westerman, Joshua M Allen, et al.Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activityNan Guo Ring, Dietmar Herndler-Brandstetter, Kipp Weiskopf, et al.Nature Communications|May 25, 2021
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymeraseRobert P Hayes, Mee Ra Heo, Mark Mason, et al.American Journal of Human Genetics|January 3, 2009
Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALSClement Y Chow, John E Landers, Sarah K Bergren, et al.Nature|March 6, 2024
Oxidative cyclization reagents reveal tryptophan cation-π interactionsXiao Xie, Patrick J Moon, Steven W M Crossley, et al.Nature Genetics|November 7, 1998
Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunctionN G Robertson, L Lu, S Heller, et al.Annals of Clinical Biochemistry|May 1, 1997
Novel instrumentation for real-time monitoring using miniaturized flow systems with integrated biosensorsR Freaney, A McShane, T V Keaveny, et al.Angewandte Chemie (International Ed. in English)|September 26, 2025
Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYCHannah T Rosen, Kelvin Li, Christian E Stieger, et al.Antimicrobial Agents and Chemotherapy|September 1, 2010
Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitorsMing-Tain Lai, Meiqing Lu, Peter J Felock, et al.Pageof 42